ALERT:

Clinical Trial

Infectious Diseases Clinical Trial 20203104

[LCID Study Number: 20203104]

Detection of SARS-CoV 2 Antibodies in Human Serum

The purpose of this study is to develop an enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 infection in human serum.

Disease/Condition: Infectious Diseases

Department: Cell and Molecular Biology Research Laboratory

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: Sanjna.Das@lahey.org

Clinical Trial Details

Protocol #: 20203104

Principal Investigator(s): Kimberly Rieger-Christ

Study Coordinator(s): Sanjna Das

Trial Phase: Investigator Initiated Study Observational